IRCT20200405046953N1招募中3 期
Randomzied trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care- Iranian SOLIDARITY multicentre trial
Iranian Ministry of Health and Medical Education, Deputy of Research and Technology0 个研究点目标入组 3,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Adults (age =18)
- •Hospitalised with definite COVID-19 diagnosis, not already receiving any of the study medications
- •No known allergy or contraindications to any of the study medications
- •Patients admitted to collaborating hospitals, without anticipated transfer within 72 hours
排除标准
- •Anyone having a significant contraindication to any one of the study drugs
- •Serious chronic liver or heat disease
研究者
相似试验
招募中
3 期
Prophylactic study for COVID-19 with Kampo medicinesJPRN-jRCTs031200150amiki Takao6,000
已完成
不适用
Trial of treatment and follow-up of vaginal intraepithelial neoplasia (VAIN)ISRCTN45751386Helsinki University Central Hospital (Finland)30
进行中（未招募）
不适用
Trial of treatment and follow-up of vaginal intraepithelial neoplasia (VAIN)VAIN, vaginal intraepithelial neoplasiaMedDRA version: 18.1Level: PTClassification code 10046890Term: Vaginal cancer stage 0System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-005377-31-FIHYKS Naistensairaala
招募中
3 期
A Randomized Controlled Trial on Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapypancreatic cancerpancreatic ductal adenocarcinoma10027656NL-OMON55290niversitair Medisch Centrum Utrecht120
进行中（未招募）
1 期
Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antiviralsCoronavirus Covid 19 infectionMedDRA version: 20.1Level: HLTClassification code 10047468Term: Viral lower respiratory tract infectionsSystem Organ Class: 100000004855EUCTR2020-001528-32-ITISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI435